CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Until recently, several glucagon-like peptide-1 (GLP-1) injections were in shortage. During this time, compounded versions became a more accessible option. Now, brand-name GLP-1 injections of ...

Semaglutide injections are helping you lose weight-but if yours isn't FDA-approved (and a lot of them aren't), it could be ...

Two GLP-1 drugs — Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. ... helping people lose 15% to 20% of their body weight, equivalent to what they ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

GLP-1 analogs have been widely used to treat patients with type 2 diabetes in recent years ... 8–12% SDS–PAGE was used to resolve equivalent amounts of protein and was then transferred to ... 40, 65, ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

Amgen's experimental obesity drug MariTide showed promising weight loss results with fewer side effects, according to a ...

Oprah Winfrey and Elon Musk endorsed it. And though Indian celebrities haven’t yet admitted to their use, the mystery ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...